AeroLeads people directory · profile

Spyros Papapetropoulos Md, Phd Email & Phone Number

President and CEO at Neuphoria Therapeutics Inc
Location: Weston, Massachusetts, United States 21 work roles 6 schools
2 work emails found @acadia-pharm.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails

Work email s****@acadia-pharm.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
President and CEO
Location
Weston, Massachusetts, United States

Who is Spyros Papapetropoulos Md, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Spyros Papapetropoulos Md, Phd is listed as President and CEO at Neuphoria Therapeutics Inc, based in Weston, Massachusetts, United States. AeroLeads shows a work email signal at acadia-pharm.com and a matched LinkedIn profile for Spyros Papapetropoulos Md, Phd.

Spyros Papapetropoulos Md, Phd previously worked as Member Board of Directors and Lead Director of Thera Phragma IKE at Phragma Therapeutics and President and CEO at Bionomics Ltd. Spyros Papapetropoulos Md, Phd holds Md, Phd, Medicine from University Of Patras.

Company email context

Email format at Neuphoria Therapeutics Inc

This section adds company-level context without repeating Spyros Papapetropoulos Md, Phd's masked contact details.

{first}@acadia-pharm.com
89% confidence

AeroLeads found 2 current-domain work email signals for Spyros Papapetropoulos Md, Phd. Compare company email patterns before reaching out.

Profile bio

About Spyros Papapetropoulos Md, Phd

Passion for discovery and development of breakthrough CNS treatments using cutting-edge science coupled with entrepreneurial spirit with a human touch

Listed skills include Neuroscience, Clinical Research, Neurology, Clinical Trials, and 41 others.

Current workplace

Spyros Papapetropoulos Md, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc
President and CEO
Weston, MA, US
AeroLeads page
21 roles

Spyros Papapetropoulos Md, Phd work experience

A career timeline built from the work history available for this profile.

Member Board Of Directors And Lead Director Of Thera Phragma Ike

Current

Phragma Therapeutics Inc. and its Greek Subsidiary Thera Phragma IKE is a biotechnology company specializing in the research and development of innovative therapies to address diseases related to the function of biological protective barriers of vital organs, such as the brain, the eye, and the intestine. The company's leading program aims to restore the.

Jul 2023 - Present

President And Ceo

Current

Eastwood, South Australia, AU

Dec 2022 - Present

Chairman And Lead Board Director

Current

Salt Lake City, Utah, US

Nov 2022 - Present

Independent Board Director

Current

Salt Lake City, Utah, US

Lipocine is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. Lipocine's technology aims at improving compliance, absorption, and more using proprietary drug delivery technologies.

Apr 2022 - Present

Founder And President

Current

Encephalos is a life sciences consulting firm passionate for data-driven discovery, development and commercialization of transformational treatments using digital innovation, artificial intelligence, cutting-edge science coupled with operational excellence, deep understanding of the regulatory environment and patient empathy.

Oct 2019 - Present

Chief Medical Officer

Watertown, MA, US

@VigilNeuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of #microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern #neuroscience drug development across multiple therapeutic modalities to.

Sep 2020 - Dec 2022

Consultant In Neurology

Boston, MA, US

Provides Residents/Fellows training and fosters academic research collaborations in the field of Movement Disorders.

Oct 2014 - Nov 2022

Independent Board Director

Emeryville, California, US

Adamas is a fully integrated pharmaceutical company experienced in drug discovery, development, and delivery of treatments for neurological diseases.We are driven by a deep sense of purpose – to make everyday life significantly better for people affected by neurological disorders.

Nov 2020 - Dec 2021

Chief Business Officer

New York, US

OccamzRazor is a machine learning (ML) powered biotech company with a unique discoveryplatform to tackle brain- aging and brain-aging related disorders starting with Parkinson’s.

Nov 2019 - Aug 2021

Chief Development Officer

San Diego, California, US

Head of the Clinical Development Function, Advisor to Acadia's President and CEO and Member of the Executive Leadership Team

Oct 2019 - Sep 2020

Board Director

Wellesley, MA, US

Development and validation of technology/digital health solutions impacting patient care, treatment and clinical research

Nov 2012 - Dec 2019

Chief Executive Officer And Board Director

Bala Cynwyd, Pennsylvania, US

Developing leading-edge gene therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases.

Apr 2019 - Oct 2019

Executive Vice President, Research And Development And Chief Medical Officer

Cavion, Inc (Acquired By Jazz Pharmaceuticals Inc)

Leads Cavion's R&D Organization (www.cavionpharma.com) with a mission to "Restore the Brain's Natural Rhythms" by modulating overactive T-type calcium channels for a range of neurological and rare genetic diseases.

May 2017 - Apr 2019

Vice President, Global Development Head, Neurodegenerative Diseases And Movement Disorders

Tel-Aviv, IL

Therapeutic Area Head responsible for clinical development strategy and execution for Neurodegeneration and Movement Disorders globally.

Feb 2015 - Jun 2017

Global Clinical Lead, Neurosciences Worldwide Research And Development

New York, New York, US

Global Clinical Lead responsible for development and execution of clinical translation and development strategies in Neurosciences. Responsible for a portfolio of 6 programs across Neurology, Psychiatry and Rare Diseases and a team of Director-level reports.

Mar 2012 - Feb 2015

Therapeutic Area Head/Neurosciences-Us, Global Medical Affairs

Dublin, Coolock, IE

Served as Medical Affairs Lead responsible for peri/post-approval & life cycle activities in Neurology/Neurosciences (movement disorders/orphan indications, spasticity, headache, pain) for multiple products (including BOTOX). Key contributor to successful NDA fillings, label expansions and product/new indication launches. Managed Medical Affairs.

May 2010 - Apr 2012

Associate Medical Director

Cambridge, MA, US

Served as the Medical Director for Biogen Idec’s neurodegenerative disease R&D portfolio (Parkinson’s disease and Alzheimer’s disease). Participated in multiple sclerosis clinical research projects

Apr 2008 - May 2010

Associate Professor Of Neurology, Director Of Research, Department Of Neurology

Miami, FL, US

Directed Clinical and Translational research in the Division of Movement disorders, Department of Neurology. Bridged basic science and clinical divisions. Was promoted 2 times in 5 years based on productivity

Nov 2003 - Mar 2008

Clinical Fellow

London, GB

Movement Disorders Clinical Fellowship. Evaluated and treated patients with various neurological disorders including Parkinson's disease, Neurodegenerative Dementias, Essential Tremor, Tics, Dystonia, Huntington's disease and participated in research projects in clinical genetics

Aug 2000 - Jul 2001
6 education records

Spyros Papapetropoulos Md, Phd education

Md, Phd, Medicine

University Of Patras

Neurology

Regional University Hospital Of Patras

Internal Medicine

General County Hospital Of Pyrgos

Education record

Patras General Regional Hospital "Saint Andreas

Medical Doctor (Md) & Doctor Of Philosophy (Phd), Medicine

University Of Patras

Md

Semmelweis University
FAQ

Frequently asked questions about Spyros Papapetropoulos Md, Phd

Quick answers generated from the profile data available on this page.

What company does Spyros Papapetropoulos Md, Phd work for?

Spyros Papapetropoulos Md, Phd works for Neuphoria Therapeutics Inc.

What is Spyros Papapetropoulos Md, Phd's role at Neuphoria Therapeutics Inc?

Spyros Papapetropoulos Md, Phd is listed as President and CEO at Neuphoria Therapeutics Inc.

What is Spyros Papapetropoulos Md, Phd's email address?

AeroLeads has found 2 work email signals at @acadia-pharm.com for Spyros Papapetropoulos Md, Phd at Neuphoria Therapeutics Inc.

Where is Spyros Papapetropoulos Md, Phd based?

Spyros Papapetropoulos Md, Phd is based in Weston, Massachusetts, United States while working with Neuphoria Therapeutics Inc.

What companies has Spyros Papapetropoulos Md, Phd worked for?

Spyros Papapetropoulos Md, Phd has worked for Neuphoria Therapeutics Inc, Phragma Therapeutics, Bionomics Ltd, Lipocine Inc., and Encephalos Life Sciences Llc.

How can I contact Spyros Papapetropoulos Md, Phd?

You can use AeroLeads to view verified contact signals for Spyros Papapetropoulos Md, Phd at Neuphoria Therapeutics Inc, including work email, phone, and LinkedIn data when available.

What schools did Spyros Papapetropoulos Md, Phd attend?

Spyros Papapetropoulos Md, Phd holds Md, Phd, Medicine from University Of Patras.

What skills is Spyros Papapetropoulos Md, Phd known for?

Spyros Papapetropoulos Md, Phd is listed with skills including Neuroscience, Clinical Research, Neurology, Clinical Trials, Pharmaceutical Industry, Medicine, Medical Affairs, and Clinical Development.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.